119 related articles for article (PubMed ID: 3186156)
1. A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck.
Senra Varela A; Millan Nuñez-Cortes J; Gallurt Moreira P
Oncology; 1988; 45(6):458-60. PubMed ID: 3186156
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
5. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
6. Combination cisplatin and carboplatin in advanced squamous cell carcinoma of the head and neck.
Patton JF; Powell BL; White DR; Russell GB; Inabinet RT; Muss HB
Cancer Invest; 1996; 14(2):98-102. PubMed ID: 8597908
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
[TBL] [Abstract][Full Text] [Related]
9. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
Rowland KM; Taylor SG; Spiers AS; DeConti RC; O'Donnell MR; Showel J; Stott PB; Milner LM; Marsh JC
Cancer Treat Rep; 1986 Apr; 70(4):461-4. PubMed ID: 3698038
[TBL] [Abstract][Full Text] [Related]
11. A phase III of cisplatinum versus cisplatinum-etoposide for previously untreated squamous cell carcinoma of the head and neck.
Marechal F; Nasca S; Morel M; Jezekova D; Coninx P; Legros M; Nguyen TD; Cattan A
Anticancer Res; 1987; 7(3 Pt B):455-8. PubMed ID: 3307601
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.
Dimery IW; Brooks BJ; Winn R; Martin T; Shirinian M; Hong WK
J Clin Oncol; 1991 Nov; 9(11):1939-44. PubMed ID: 1941052
[TBL] [Abstract][Full Text] [Related]
14. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
17. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Herbst RS; Arquette M; Shin DM; Dicke K; Vokes EE; Azarnia N; Hong WK; Kies MS
J Clin Oncol; 2005 Aug; 23(24):5578-87. PubMed ID: 16009949
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin and mitoguazone. An induction chemotherapy regimen in advanced head and neck cancer.
Forastiere AA; Perry DJ; Wolf GT; Wheeler RH; Natale RB
Cancer; 1988 Dec; 62(11):2304-8. PubMed ID: 3179946
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
Kohno N; Kitahara S; Tamura E; Tanabe T
Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]